Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen for relapsed and refractory multiple myeloma patients [1]

Stefania Ciolli, F. Leoni, F. Gigli, L. Rigacci, A. Bosi

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen for relapsed and refractory multiple myeloma patients [1]'. Together they form a unique fingerprint.

Medicine & Life Sciences